Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Cα and the PDZ adapter protein mda-9/syntenin

Cancer Research

Volumn 70, Issue 4, 2010, Pages 1645-1655

  Hwangbo, Cheol ^a   Kim, Jaekyung ^a   Lee, Jung Joon ^b   Lee, Jeong Hyung ^a  

^a Kangwon National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PDZ PROTEIN; PROTEIN CDC42; PROTEIN KINASE C ALPHA; SYNTENIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL FRACTIONATION; CELL MIGRATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA; METASTASIS; ONCOGENE SRC; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANTIGENS, CD29; CELL ADHESION; ENZYME ACTIVATION; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PDZ DOMAINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; PROTEIN-TYROSINE KINASES; RECEPTOR CROSS-TALK; RNA, SMALL INTERFERING; SYNTENINS; TUMOR CELLS, CULTURED;

EID: 76749169432     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2447     Document Type: Article

References (39)

1. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997;278:2075-80.
2. Hung AY, Sheng M. PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002;277:5699-702.
3. Koroll M, Rathjen FG, Volkmer H. The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self associating activity. J Biol Chem 2001; 276:10646-54.
4. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 2008;68:3087-93.
5. Beekman JM, Coffer PJ. The ins and outs of syntenin, a multi-functional intracellular adaptor protein. J Cell Sci 2008;121: 1349-55.
6. Grembecka J, Cierpicki T, Devedjiev Y, et al. The binding of the PDZ tandem of syntenin to target proteins. Biochemistry 2006;45: 3674-83.
7. Kang BS, Cooper DR, Jelen F, et al. PDZ tandem of human syntenin: crystal structure and functional properties. Structure 2003;11: 459-68.
8. Boukerche H, Su ZZ, Emdad L, et al. mda-9/syntenin: a positive regulator of melanoma metastasis. Cancer Res 2005;65:10901-11.
9. Boukerche H, Su ZZ, Prévot C, Sarkar D, Fisher PB. mda-9/syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci U S A 2008;105:15914-9.
10. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. mda-9/syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-κB. Cancer Res 2007;67:1812-22.
11. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 2002;21:4080-8.
12. Meerschaert K, Bruyneel E, De Wever O, et al. The tandem PDZ domains of syntenin promote cell invasion. Exp Cell Res 2007;313: 1790-804.
13. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004;6:209-14.
14. Watt FM. Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 2002;21:3919-26.
15. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87.
16. 1-integrin- linked protein kinase. Nature 1996;379:1-96.
17. Schaller MD, Parsons JT. Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6:705-10.
18. Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 2006;18:516-23.
19. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6:56-68.
20. Shi Q, Boettiger D. A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397. Mol Bio Cell 2003;14:4306-15.
21. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954-63.
22. Owen JD, Ruest PJ, Fry DW, Hanks SK. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both. Mol Cell Biol 1999;19:4806-18.
23. Schlaepfer DD, Mitra SK, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 2004; 1692:77-102.
24. 1 integrin-mediated cell spreading on fibronectin. J Biol Chem 1993; 268:21459-62.
25. laepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372:786-91.
26. Movich B, Kaneshiki N, Ji P. Protein kinase C regulates tyrosine phosphorylation of pp125FAK in platelets adherent to fibrinogen. Blood 1996;87:152-61.
27. Woods A, Couchman JR. Protein kinase C involvement in focal adhesion formation. J Cell Sci 1992;101:277-90.
28. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-9.
29. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 2007;8: 957-69.
30. Joo NE, Watanabe T, Chen C, Chekenya M, Stallcup WB, Kapila YL. NG2, a novel proapoptotic receptor, opposes integrin α4 to mediate anoikis through PKCα-dependent suppression of FAK phosphorylation. Cell Death Differ 2008;15:899-907.
31. Mostafavi-Pour Z, Askari JA, Parkinson SJ, Parker PJ, Ng TT, Humphries MJ. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J Cell Biol 2003;161:155-67.
32. Kim KK, Lee JJ, Yang Y, You KH, Lee JH. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 2008;29:704-12.
33. Cho W. Membrane targeting by C1 and C2 domains. J Biol Chem 2001;276:32407-10.
34. Wilcox-Adelman SA, Denhez F, Goetinck PF. Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem 2002;277: 32970-7.
35. Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem 1998;273:10624-9.
36. Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A 1997;94:13683-8.
37. Zimmermann P, Meerschaert K, Reekmans G, et al. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 2002;9:1215-25.
38. 2 ligand itself influences the localization of PKCα in the plasma membrane of intact living cells. J Mol Biol 2008;377:1038-52.
39. 2+-dependent PtdIns(4,5) P2 sensing domain: a new insight into an old pathway. J Mol Biol 2006;362:901-14.